RxDoctor Payments Data

Justin Cohen

Neurological Surgery · Saint Paul, MNNPI 1508367277

Payments from drug & device makers

What this record shows

11 manufacturers reported payments, led by Medtronic at 52.8% of the total. Reporting peaked in 2023 at $3,314 and has fallen 97.2% since, to $92 in 2025.

$5,236in general payments, 2019–2025

Across 57 payments — averaging $91.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Globus Medical$2K
  • Johnson & Johnson$330
  • Abbott$291
  • Sanara Medtech Inc.$161
  • Medical Device Business Services, Inc.$50
  • plus $132 from 5 others
$41,951in research payments, 2019–2025

Across 4 payments — averaging $10,488 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Misonix Inc$23K
  • Medtronic$19K

What the payments were for

  • Travel & lodging$2,72952%
  • Food & beverage$2,50648%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,236 in reported general payments places this provider in the 75th percentile of 140 neurological surgery providers in Minnesota.

See all neurological surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$74,667
Medicare patients
168
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin38$406
Ibuprofen21$107
Naproxen16$38

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →